These findings have potentially important implications for pediatric neuroblastoma, where mutation of human ALK at orthologous sites (ALK-Y1278S and ALK-F1174L) is associated with tumor progression in the developing peripheral nervous system. This evidence concerns the gene ALK and neoplasm.